VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q63378752 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010849.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q63378752‏
024 ‎‡a 0000-0002-8578-5921‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q63378752‏
100 0 ‎‡a Keith J Johnson‏ ‎‡9 es‏ ‎‡9 ast‏
400 0 ‎‡a কিথ জে জনসন‏ ‎‡9 bn‏
400 0 ‎‡a Keith Johnson‏ ‎‡9 de‏
400 0 ‎‡a Keith J Johnson‏ ‎‡c biologist‏ ‎‡9 en‏
400 0 ‎‡a Keith J Johnson‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's Chronic myopathy in a patient suspected of carrying two malignant hyperthermia susceptibility‏
670 ‎‡a Author's Chronic myopathy in a patient suspected of carrying two malignant hyperthermia susceptibility (MHS) mutations‏
670 ‎‡a Author's Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations‏
670 ‎‡a Author's Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling and the need for a personalized medicine approach to identify primary non-responders‏
670 ‎‡a Author's Expansion of unstable DNA region in Japanese myotonic dystrophy patients‏
670 ‎‡a Author's Gene expression profiling of immunomagnetically separated cells directly from stabilized whole blood for multicenter clinical trials‏
670 ‎‡a Author's Genetic diversity in black South Africans from Soweto‏
670 ‎‡a Author's Genetics and Physiology of the Myotonic Muscle Disorders‏
670 ‎‡a Author's Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach‏
670 ‎‡a Author's LMX1B mutations cause hereditary FSGS without extrarenal involvement‏
670 ‎‡a Author's Molecular genetics diagnosis of Steinert's myotonic dystrophy‏
670 ‎‡a Author's Myotonic dystrophy: another case of too many repeats?‏
670 ‎‡a Author's Preparative Scale, High Resolution Purification of Low Molecular Weight DNA Fragments‏
670 ‎‡a Author's Race and ethnicity in the era of emerging pharmacogenomics.‏
670 ‎‡a Author's Radiation-reduced hybrids for the myotonic dystrophy locus‏
670 ‎‡a Author's Robust and tissue-independent gender-specific transcript biomarkers.‏
670 ‎‡a Author's The expression of mmp-7 messenger-RNA in primary and metastatic human colorectal adenocarcinoma‏
670 ‎‡a Author's The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG).‏
670 ‎‡a Author's Two sequence-tagged sites defining the ends of a 380 kb YAC clone from 19q13‏
670 ‎‡a Author's Unstable DNA fragment can disclose carriers of dystrophia myotonica‏
670 ‎‡a Author's Waiting for frataxin‏
909 ‎‡a (orcid) 0000000285785921‏ ‎‡9 1‏
919 ‎‡a roleofadmepharmacogenomicsinearlyclinicaltrialsperspectiveoftheindustrypharmacogenomicsworkinggroup1pwg‏ ‎‡A The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG).‏ ‎‡9 1‏
919 ‎‡a 2sequencetaggedsitesdefiningtheendsofa380kbyacclonefrom19q13‏ ‎‡A Two sequence-tagged sites defining the ends of a 380 kb YAC clone from 19q13‏ ‎‡9 1‏
919 ‎‡a unstablednafragmentcandisclosecarriersofdystrophiamyotonica‏ ‎‡A Unstable DNA fragment can disclose carriers of dystrophia myotonica‏ ‎‡9 1‏
919 ‎‡a waitingforfrataxin‏ ‎‡A Waiting for frataxin‏ ‎‡9 1‏
919 ‎‡a chronicmyopathyinapatientsuspectedofcarrying2malignanthyperthermiasusceptibility‏ ‎‡A Chronic myopathy in a patient suspected of carrying two malignant hyperthermia susceptibility‏ ‎‡9 1‏
919 ‎‡a chronicmyopathyinapatientsuspectedofcarrying2malignanthyperthermiasusceptibilitymhsmutations‏ ‎‡A Chronic myopathy in a patient suspected of carrying two malignant hyperthermia susceptibility (MHS) mutations‏ ‎‡9 1‏
919 ‎‡a comparisonofthemyotonicdystrophyassociatedctgrepeatineuropeanandjapanesepopulations‏ ‎‡A Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations‏ ‎‡9 1‏
919 ‎‡a definingresponsetotnfinhibitorsinrheumatoidarthritisthenegativeimpactofantitnfcyclingandtheneedforapersonalizedmedicineapproachtoidentifyprimarynonresponders‏ ‎‡A Defining response to TNF-inhibitors in rheumatoid arthritis: the negative impact of anti-TNF cycling and the need for a personalized medicine approach to identify primary non-responders‏ ‎‡9 1‏
919 ‎‡a expansionofunstablednaregioninjapanesemyotonicdystrophypatients‏ ‎‡A Expansion of unstable DNA region in Japanese myotonic dystrophy patients‏ ‎‡9 1‏
919 ‎‡a geneexpressionprofilingofimmunomagneticallyseparatedcellsdirectlyfromstabilizedwholebloodformulticenterclinicaltrials‏ ‎‡A Gene expression profiling of immunomagnetically separated cells directly from stabilized whole blood for multicenter clinical trials‏ ‎‡9 1‏
919 ‎‡a geneticdiversityinblacksouthafricansfromsoweto‏ ‎‡A Genetic diversity in black South Africans from Soweto‏ ‎‡9 1‏
919 ‎‡a geneticsandphysiologyofthemyotonicmuscledisorders‏ ‎‡A Genetics and Physiology of the Myotonic Muscle Disorders‏ ‎‡9 1‏
919 ‎‡a identifyinggeneticriskvariantsforcoronaryheartdiseaseinfamilialhypercholesterolemiaanextremegeneticsapproach‏ ‎‡A Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach‏ ‎‡9 1‏
919 ‎‡a lmx1bmutationscausehereditaryfsgswithoutextrarenalinvolvement‏ ‎‡A LMX1B mutations cause hereditary FSGS without extrarenal involvement‏ ‎‡9 1‏
919 ‎‡a moleculargeneticsdiagnosisofsteinertsmyotonicdystrophy‏ ‎‡A Molecular genetics diagnosis of Steinert's myotonic dystrophy‏ ‎‡9 1‏
919 ‎‡a myotonicdystrophyanothercaseoftoomanyrepeats‏ ‎‡A Myotonic dystrophy: another case of too many repeats?‏ ‎‡9 1‏
919 ‎‡a preparativescalehighresolutionpurificationoflowmolecularweightdnafragments‏ ‎‡A Preparative Scale, High Resolution Purification of Low Molecular Weight DNA Fragments‏ ‎‡9 1‏
919 ‎‡a raceandethnicityintheeraofemergingpharmacogenomics‏ ‎‡A Race and ethnicity in the era of emerging pharmacogenomics.‏ ‎‡9 1‏
919 ‎‡a radiationreducedhybridsforthemyotonicdystrophylocus‏ ‎‡A Radiation-reduced hybrids for the myotonic dystrophy locus‏ ‎‡9 1‏
919 ‎‡a robustandtissueindependentgenderspecifictranscriptbiomarkers‏ ‎‡A Robust and tissue-independent gender-specific transcript biomarkers.‏ ‎‡9 1‏
919 ‎‡a expressionofmmp7messengerrnainprimaryandmetastatichumancolorectaladenocarcinoma‏ ‎‡A The expression of mmp-7 messenger-RNA in primary and metastatic human colorectal adenocarcinoma‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000115292921
996 ‎‡2 SUDOC|029102405
996 ‎‡2 DNB|173571441
996 ‎‡2 LC|n 2002040996
996 ‎‡2 ISNI|0000000037830105
996 ‎‡2 NUKAT|n 98031421
996 ‎‡2 LC|n 92111229
996 ‎‡2 NDL|00444783
996 ‎‡2 NII|DA15201924
996 ‎‡2 BIBSYS|90667434
996 ‎‡2 DNB|133168689
996 ‎‡2 LC|n 50039838
996 ‎‡2 J9U|987007374408005171
996 ‎‡2 BNC|981058521020506706
996 ‎‡2 J9U|987007376920705171
996 ‎‡2 SELIBR|378070
996 ‎‡2 ISNI|0000000040074742
996 ‎‡2 NTA|074248197
996 ‎‡2 LC|no2014010839
996 ‎‡2 DNB|1018140921
996 ‎‡2 ISNI|0000000080839156
996 ‎‡2 BNF|11908900
996 ‎‡2 J9U|987007446157405171
996 ‎‡2 NLB|18583704
996 ‎‡2 LC|no2008181118
996 ‎‡2 NTA|144515180
996 ‎‡2 SIMACOB|82213987
996 ‎‡2 J9U|987007436196605171
996 ‎‡2 LC|n 82021989
996 ‎‡2 J9U|987007966885405171
996 ‎‡2 ISNI|0000000024710593
996 ‎‡2 LC|n 2023043512
996 ‎‡2 LC|no2006018946
996 ‎‡2 BIBSYS|90740004
996 ‎‡2 J9U|987007342331305171
996 ‎‡2 NTA|131629654
996 ‎‡2 LC|n 00145298
996 ‎‡2 RERO|A003427840
996 ‎‡2 ISNI|0000000047492605
996 ‎‡2 LC|n 79080468
996 ‎‡2 N6I|vtls000093819
996 ‎‡2 LNB|LNC10-000121124
996 ‎‡2 DBC|87097991130548
996 ‎‡2 NLA|000035442030
996 ‎‡2 LNB|LNC10-000121128
996 ‎‡2 LC|n 2011009043
996 ‎‡2 DNB|133268608
996 ‎‡2 LC|n 81016377
996 ‎‡2 LC|n 80007661
996 ‎‡2 ISNI|0000000035851420
996 ‎‡2 BNF|17891816
996 ‎‡2 J9U|987007381732105171
996 ‎‡2 LC|n 85246792
996 ‎‡2 NII|DA07493904
996 ‎‡2 NKC|utb2012701625
996 ‎‡2 SUDOC|243258054
996 ‎‡2 LIH|LNB:BZ8T;=BU
996 ‎‡2 SUDOC|123245788
996 ‎‡2 KRNLK|KAC200702943
996 ‎‡2 NII|DA08247991
996 ‎‡2 LC|nb2006001990
996 ‎‡2 DNB|1052549012
996 ‎‡2 LC|no2018022292
996 ‎‡2 SUDOC|257252657
996 ‎‡2 LC|nb2006021664
996 ‎‡2 CAOONL|ncf11212220
996 ‎‡2 NTA|132127792
996 ‎‡2 LC|no 98021891
996 ‎‡2 LC|n 85275809
996 ‎‡2 ISNI|0000000040880955
996 ‎‡2 ISNI|0000000043315468
996 ‎‡2 NII|DA05766303
996 ‎‡2 ISNI|0000000037875688
996 ‎‡2 ISNI|0000000080195223
996 ‎‡2 CAOONL|ncf11296959
996 ‎‡2 NUKAT|n 2004022830
996 ‎‡2 J9U|987007317144205171
996 ‎‡2 LC|n 00036631
996 ‎‡2 BIBSYS|3047376
996 ‎‡2 ISNI|0000000393571410
996 ‎‡2 LC|no 95049291
996 ‎‡2 NTA|325845697
996 ‎‡2 CAOONL|ncf10466840
996 ‎‡2 SUDOC|179244965
996 ‎‡2 DNB|1165151731
996 ‎‡2 NII|DA10368773
996 ‎‡2 CAOONL|ncf11329620
996 ‎‡2 ISNI|0000000082553602
996 ‎‡2 NTA|069365792
996 ‎‡2 DNB|1050315766
996 ‎‡2 SUDOC|203111907
996 ‎‡2 BIBSYS|90169262
996 ‎‡2 NLA|000035249200
996 ‎‡2 NII|DA08052937
996 ‎‡2 BNC|981058611771506706
996 ‎‡2 BNF|12079833
996 ‎‡2 ISNI|0000000044888671
996 ‎‡2 SIMACOB|137849443
996 ‎‡2 NKC|jo2018998652
996 ‎‡2 NTA|070562040
996 ‎‡2 BNF|11515839
996 ‎‡2 BNF|15125225
996 ‎‡2 LC|no2004055915
996 ‎‡2 LC|no2023141201
996 ‎‡2 NSK|000354180
996 ‎‡2 ISNI|0000000035776061
996 ‎‡2 ISNI|0000000035295516
996 ‎‡2 ISNI|0000000030927377
996 ‎‡2 LNB|LNC10-000278049
996 ‎‡2 ISNI|0000000067096992
996 ‎‡2 SUDOC|279586477
996 ‎‡2 NUKAT|n 2004251373
996 ‎‡2 NUKAT|n 2016140683
996 ‎‡2 ISNI|0000000447091835
996 ‎‡2 BIBSYS|4021104
996 ‎‡2 ISNI|000000004283176X
996 ‎‡2 LC|n 80161078
996 ‎‡2 LC|n 2005080727
996 ‎‡2 RERO|A022514844
996 ‎‡2 J9U|987007429801405171
996 ‎‡2 CAOONL|ncf10113681
996 ‎‡2 LC|n 94089953
996 ‎‡2 LC|nb2010016863
996 ‎‡2 BIBSYS|90209047
996 ‎‡2 LC|n 2004044021
996 ‎‡2 NLA|000036267724
996 ‎‡2 LNB|LNC10-000135100
996 ‎‡2 LC|n 2012010482
996 ‎‡2 SUDOC|183726952
996 ‎‡2 LC|n 87883307
996 ‎‡2 NLA|000036226194
996 ‎‡2 LC|no2001057677
996 ‎‡2 LC|n 93080402
996 ‎‡2 LC|n 96042620
996 ‎‡2 LC|no2020150176
996 ‎‡2 BIBSYS|90096682
996 ‎‡2 NTA|345708261
996 ‎‡2 CAOONL|ncf10650094
996 ‎‡2 LC|no2008081377
996 ‎‡2 ISNI|0000000024899103
996 ‎‡2 SUDOC|227137566
996 ‎‡2 LC|n 2017040991
996 ‎‡2 ISNI|0000000025211083
996 ‎‡2 DNB|133268624
996 ‎‡2 LC|n 88156439
996 ‎‡2 ISNI|0000000063971585
996 ‎‡2 SUDOC|266266711
996 ‎‡2 NLA|000036109284
996 ‎‡2 LC|nr 00031235
996 ‎‡2 DNB|1309681848
996 ‎‡2 ISNI|0000000034546176
996 ‎‡2 BNF|15963170
996 ‎‡2 BNF|17014768
996 ‎‡2 LC|n 88649704
996 ‎‡2 ERRR|a12522417
996 ‎‡2 LC|no2015093204
996 ‎‡2 ISNI|0000000040800054
996 ‎‡2 BIBSYS|99067813
996 ‎‡2 SUDOC|080406181
996 ‎‡2 NUKAT|nx2024244327
996 ‎‡2 BIBSYS|51690
996 ‎‡2 CAOONL|ncf13731924
996 ‎‡2 LC|n 2006038864
996 ‎‡2 NUKAT|n 2012166228
996 ‎‡2 SUDOC|026939169
996 ‎‡2 ISNI|0000000507173251
996 ‎‡2 ISNI|0000000122144433
996 ‎‡2 LC|no2010163970
996 ‎‡2 NKC|jo2013757965
996 ‎‡2 LC|nb2007026301
996 ‎‡2 N6I|vtls002647495
996 ‎‡2 J9U|987007389982605171
996 ‎‡2 ISNI|0000000035510941
996 ‎‡2 ISNI|0000000050545325
996 ‎‡2 RERO|A010968051
996 ‎‡2 LC|n 98800814
996 ‎‡2 ISNI|000000005052994X
996 ‎‡2 ISNI|0000000395058784
996 ‎‡2 LIH|LNB:B_j__i__c_;=CC
996 ‎‡2 ISNI|0000000471448435
996 ‎‡2 ISNI|0000000083041895
996 ‎‡2 LNB|LNC10-000120505
996 ‎‡2 PLWABN|9813273792905606
996 ‎‡2 CAOONL|ncf10991448
996 ‎‡2 LNB|LNC10-000120501
996 ‎‡2 ISNI|0000000110604009
996 ‎‡2 BIBSYS|51687
996 ‎‡2 NII|DA08101511
996 ‎‡2 RERO|A005812625
996 ‎‡2 DBC|87097919323951
996 ‎‡2 J9U|987012798303005171
996 ‎‡2 SUDOC|120685663
996 ‎‡2 LC|n 98901688
996 ‎‡2 NTA|069008736
996 ‎‡2 PLWABN|9814006620005606
996 ‎‡2 BNF|17771323
996 ‎‡2 ISNI|0000000110077544
996 ‎‡2 NII|DA00671425
996 ‎‡2 LC|nb2019010868
996 ‎‡2 LC|n 2003098856
996 ‎‡2 NTA|15754639X
996 ‎‡2 SUDOC|187922632
996 ‎‡2 ISNI|0000000043366046
996 ‎‡2 NKC|mzk2005312737
996 ‎‡2 SZ|1018140921
996 ‎‡2 J9U|987007440071405171
996 ‎‡2 ISNI|0000000041760701
996 ‎‡2 ISNI|0000000027209673
996 ‎‡2 ISNI|0000000086108645
996 ‎‡2 BIBSYS|12007263
996 ‎‡2 LC|n 80126185
996 ‎‡2 SUDOC|181160978
996 ‎‡2 LC|nb2007025672
996 ‎‡2 ISNI|0000000047704057
996 ‎‡2 LC|n 2007045285
996 ‎‡2 ISNI|0000000067702059
996 ‎‡2 NYNYRILM|116833
996 ‎‡2 RERO|A012485318
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏